共 50 条
- [41] INTRAPERITONEAL RECOMBINANT HUMAN GROWTH-HORMONE (RHGH) TO IMPROVE THE SHORT STATURE ASSOCIATED WITH CHRONIC-RENAL-FAILURE IN PEDIATRIC PERITONEAL-DIALYSIS PATIENTS JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 344 - 344
- [44] Paternal deletion of the GNAS imprinted locus (including Gnasxl) in two girls presenting with severe pre- and post-natal growth retardation and intractable feeding difficulties European Journal of Human Genetics, 2005, 13 : 1033 - 1039
- [48] LONG-TERM EFFICACY AND SAFETY OF TWO DOSES OF NORDITROPIN® (HUMAN GROWTH HORMONE, SOMATROPIN) IN SHORT STATURE DUE TO NOONAN SYNDROME: A RANDOMIZED, DOUBLE-BLIND, MULTICENTER TRIAL IN JAPANESE PATIENTS HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 305 - 306
- [49] A trial investigating the long-term efficacy and safety of two doses of Norditropin® (somatropin; recombinant human growth hormone) in Japanese children with short stature due to Noonan syndrome over four years of treatment HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 345 - 345
- [50] Comparison of response to 2-years' growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic short stature, or multiple pituitary hormone deficiency: combined results from two large observational studies INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2012,